Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 1 to 10 of 270 resources
-
HCV Action and Public Health England hepatitis C good practice roadshow, West London: Presentations
On 27th September 2019, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow with the West London ODN. The event featured presentations on progress in tackling hepatitis C, nationally and locally, and examples of best practice in the prevention, diagnosis, testing and treatment of hepatitis C.UK, England, Greater London 07 Oct 2019 Training, Strategy & Planning PDF -
Public Health England Hepatitis C in the UK 2019 Report
Public Health England published its annual 'Hepatitis C in the UK' report on 13th September 2019. This is the key national reporting document for hepatitis C and monitors the UK's progress towards its goal of eliminating the virus by 2030. This year's report finds that although fewer people are living with chronic hepatitis C than in previous years, the proportion of these people who do not know they are infected has increased to two-thirds (up from half).UK Reports & Research, Strategy & Planning PDF -
Public Health England's Infectious Diseases Strategy 2020-25
Public Health England published 'PHE Infectious Diseases Strategy 2020-25: Addressing urgent threats in the 21st century' in September 2019. The strategy sets out PHE's 10 priorities for infectious diseases over the next five years and how they will achieve these. Of particular relevance to hepatitis C is priority 4, which aims to "Eliminate hepatitis B and C, Tuberculosis and HIV and halt the rise in sexually transmitted infections in our population". The document states PHE will "enable work on detection, surveillance and control of HIV, hepatitis B, C, and TB".UK, England Reports & Research PDF -
Joining the dots: Linking pathways to hepatitis C diagnosis and treatment
This report from the London Joint Working Group on Substance Use and Hepatitis C explores how effective data sharing can lead to quicker, easier access to care for people with hepatitis C. From interviews with various stakeholders, two main barriers to effective data sharing are identified: (1) confusion about who data can be shared with and under what circumstances, (2) a lack of computer systems that enable care providers to easily share patient data.England, Greater London Reports & Research PDF -
Scotland’s Hepatitis C Action Plan: Achievements of the First Decade and Proposals for a Scottish Government Strategy (2019) for the Elimination of both Infection and Disease
This report reflects on how the Scottish Government's Hepatitis C Action Plan was established and what it has achieved a decade after its launch. It also reflects on changing Government policy over this time and sets out future policy to achieve the elimination of hepatitis C.Scotland 31 Jul 2019 Reports & Research, Strategy & Planning PDF -
Hepatitis C: interventions for patient case-finding and linkage to care
Published in July 2019 this review summarizes the evidence for interventions to increase case-finding and linkage to care for hepatitis C-infected patients, in order to support commissioning and provision of evidence-based interventions as part of efforts to achieve hepatitis C (HCV) elimination as a major public health threat in the UK.UK, England, Northern Ireland, Scotland, Wales 30 Jul 2019 Reports & Research PDF -
Legal Barriers for Providing HCV Community Testing in Europe
This report from the Correlation European Harm Reduction Network is based on a telephone survey conducted in September and October 2018 with representatives of harm reduction services and NGOs that offer low-threshold services to drug users.UK, Rest of World Reports & Research PDF -
HCV Action & BVHG National Hepatitis C ODN Stakeholder Event: Presentations
On Thursday 4th July, HCV Action held a National Hepatitis C ODN Stakeholder Event, in partnership with the British Viral Hepatitis Group. The event - HCV Action's biggest to date - brought ODN representatives together to discuss the opportunities and challenges associated with the recently-announced NHS England elimination deal.England 30 Jul 2019 Training, Reports & Research, Strategy & Planning PDF -
Summary report: National Hepatitis C ODN Stakeholder Event
This report provides a summary of the the breakout sessions held during the HCV Action & British Viral Hepatitis Group National Hepatitis C ODN Stakeholder Event, which took place at the University of Warwick on 4th July 2019. The breakout sessions were held in two parts, the first focusing on problem identification and the second on identifying solutions, and focused on the following topics: community outreach; reaching ethnic minority groups; treating in prisons; and engaging with local commissioners & other partners.England 30 Jul 2019 Training, Reports & Research, Strategy & Planning PDF -
EMCDDA on models of care for hepatitis C in drugs services
The European Monitoring Centre for Drugs and Drug Addiction published 'Hepatitis C: new models of care for drugs services' in July 2019. This aims to highlight the importance of targeting people who inject drugs as a key population for the elimination of hepatitis C in Europe and to show innovative practice in the form of 11 case studies (three of which are from England). The report provides key insights into the results, impact, sustainability and transferability of each practice to guide the implementation of these new models of care in other countries and settings.UK, Rest of World, England, Greater London 29 Jul 2019 Reports & Research, Strategy & Planning PDF